Home The Word Brain	My Amedeo FAQ Privacy About
	Explore this week’s CC Journal Club 90‑sec video • 4‑min audio • paper abstracts

Colorectal Neoplasms

Free Subscription Articles published in J Natl Cancer Inst Retrieve available abstracts of 35 articles: HTML format

Single Articles

April 2025
1. KUMAR R, Hallemeier CL, Chang DT, Lu SE, et al
   Increased occurrence of malignancy before and after chemoradiation for anal squamous cell carcinoma: a multi-institutional analysis.
   J Natl Cancer Inst. 2025;117:772-780.
   PubMed     Abstract available
   
   
   
2. SANTUCCI C, Mignozzi S, Alicandro G, Pizzato M, et al
   Trends in cancer mortality under age 50 in 15 upper-middle and high-income countries.
   J Natl Cancer Inst. 2025;117:747-760.
   PubMed     Abstract available
   
   
   February 2025
3. LIU Y, Song M, Giovannucci EL, Platz EA, et al
   Pre- and post-diagnostic use of antihypertensive medications and stage I-III colorectal cancer survival: prospective cohort study.
   J Natl Cancer Inst. 2025 Feb 25:djaf046. doi: 10.1093.
   PubMed     Abstract available
   
   
   
4. HU P, Prorok PC, Katki HA
   Design of randomized controlled trials to estimate cancer-mortality reductions from multicancer detection screening.
   J Natl Cancer Inst. 2025;117:303-311.
   PubMed     Abstract available
   
   
   
5. TROESTER A, Parikh R, Southwell B, Ester E, et al
   Treatment of stage I-III squamous cell anal cancer: a comparative effectiveness systematic review.
   J Natl Cancer Inst. 2025;117:240-252.
   PubMed     Abstract available
   
   
   January 2025
6. MEZGER NCS, Seraphin TP, Balle R, Griesel M, et al
   NCCN guideline-concordant cancer care in sub-Saharan Africa: a population-based multicountry study of 5 cancers.
   J Natl Cancer Inst. 2025;117:120-133.
   PubMed     Abstract available
   
   
   December 2024
7. HU Q, Yang X, Sun Y
   Re: Characteristics of a cost-effective blood test for colorectal cancer screening.
   J Natl Cancer Inst. 2024 Dec 24:djae340. doi: 10.1093.
   PubMed    
   
   
   
8. LI X, Hur J, Zhang Y, Song M, et al
   Drinking pattern and time lag of alcohol consumption with colorectal cancer risk in US men and women.
   J Natl Cancer Inst. 2024 Dec 17:djae330. doi: 10.1093.
   PubMed     Abstract available
   
   
   November 2024
9. JUDGE SJ, Malekzadeh P, Corines MJ, Gollub MJ, et al
   Watch and wait in rectal cancer patients with residual mucin on magnetic resonance imaging following neoadjuvant therapy.
   J Natl Cancer Inst. 2024;116:1761-1766.
   PubMed     Abstract available
   
   
   October 2024
10. DOWNIE JM, Joshi AD, Geraghty CM, Guercio BJ, et al
    Novel metabolomic predictors of incident colorectal cancer in men and women.
    J Natl Cancer Inst. 2024 Oct 28:djae270. doi: 10.1093.
    PubMed     Abstract available
    
    
    
11. HU Q, Zhou X, Sun Y
    RE: Combining antivascular endothelial growth factor and anti-epidermal growth factor receptor antibodies: randomized phase II study of irinotecan and cetuximab with/without ramucirumab in second-line colorectal cancer (ECOG-ACRIN E7208).
    J Natl Cancer Inst. 2024 Oct 16:djae257. doi: 10.1093.
    PubMed    
    
    
    
12. VAN DEN PUTTELAAR R, Shi KS, Smith R, Zhao J, et al
    Implications of the initial braidwood v. Becerra ruling for colorectal cancer outcomes: a modeling study.
    J Natl Cancer Inst. 2024 Oct 3:djae244. doi: 10.1093.
    PubMed     Abstract available
    
    
    
13. KATKI HA, Prorok PC, Castle PE, Minasian LM, et al
    Increasing power in screening trials by testing control-arm specimens: application to multicancer detection screening.
    J Natl Cancer Inst. 2024;116:1675-1682.
    PubMed     Abstract available
    
    
    September 2024
14. ZHAO J, Xue E, Zhou S, Zhang M, et al
    Allostatic Load, Genetic Susceptibility, Incidence Risk, and All-cause Mortality of Colorectal Cancer.
    J Natl Cancer Inst. 2024 Sep 13:djae223. doi: 10.1093.
    PubMed     Abstract available
    
    
    
15. GARG A, Damgacioglu H, Sigel K, Nyitray AG, et al
    Future patterns in burden and incidence of squamous cell carcinoma of the anus in the United States, 2001-2035.
    J Natl Cancer Inst. 2024;116:1508-1512.
    PubMed     Abstract available
    
    
    
16. DESHMUKH AA, Lin YY, Damgacioglu H, Shiels M, et al
    Recent and projected incidence trends and risk of anal cancer among people with HIV in North America.
    J Natl Cancer Inst. 2024;116:1450-1458.
    PubMed     Abstract available
    
    
    August 2024
17. CHENG E, Ou FS, Gatten C, Ma C, et al
    Plant-Based Diet and Survival Among Patients with Metastatic Colorectal Cancer.
    J Natl Cancer Inst. 2024 Aug 30:djae213. doi: 10.1093.
    PubMed     Abstract available
    
    
    
18. BROWN JC, Ma C, Shi Q, Couture F, et al
    Inflammation, Physical Activity, and Disease-Free Survival in Stage III Colon Cancer: CALGB/SWOG 80702 (Alliance).
    J Natl Cancer Inst. 2024 Aug 24:djae203. doi: 10.1093.
    PubMed     Abstract available
    
    
    
19. LIANG PS, Bhatt D
    Modeling disparities in colorectal cancer outcomes: colonoscopy follow-up and quality are key.
    J Natl Cancer Inst. 2024 Aug 8:djae176. doi: 10.1093.
    PubMed    
    
    
    
20. RIM SH, Beer L, Saraiya M, Tie Y, et al
    Prevalence of anal cytology screening among persons with HIV and lack of access to high-resolution anoscopy at HIV care facilities.
    J Natl Cancer Inst. 2024;116:1319-1332.
    PubMed     Abstract available
    
    
    
21. GUPTA A, O'Callaghan CJ, Zhu L, Jonker DJ, et al
    The association of health-care contact days with physical function and survival in CCTG/AGITG CO.17.
    J Natl Cancer Inst. 2024;116:1313-1318.
    PubMed     Abstract available
    
    
    
22. KATKI HA, Prorok PC, Castle PE, Minasian LM, et al
    Increasing power in screening trials by testing control-arm specimens: application to multicancer detection screening.
    J Natl Cancer Inst. 2024;116:1280-1287.
    PubMed     Abstract available
    
    
    
23. BERRY E, Hostetter J, Bachtold J, Zamarripa S, et al
    Evaluating colonoscopy quality by performing provider type.
    J Natl Cancer Inst. 2024;116:1264-1269.
    PubMed     Abstract available
    
    
    July 2024
24. ALAGOZ O, May FP, Doubeni CA, Fendrick AM, et al
    Impact of racial disparities in follow-up and quality of colonoscopy on colorectal cancer outcomes.
    J Natl Cancer Inst. 2024 Jul 24:djae140. doi: 10.1093.
    PubMed     Abstract available
    
    
    June 2024
25. TSAI YY, Nair KG, Barot SV, Xiang S, et al
    Differences in Tumor-Associated T cell receptor repertoires between Early-Onset and Average-Onset colorectal cancer.
    J Natl Cancer Inst. 2024 Jun 20:djae143. doi: 10.1093.
    PubMed     Abstract available
    
    
    
26. SONG Y, Loomans-Kropp H, Baugher RN, Somerville B, et al
    Frameshift mutations in peripheral blood as a biomarker for surveillance of Lynch syndrome.
    J Natl Cancer Inst. 2024;116:957-965.
    PubMed     Abstract available
    
    
    
27. YATES J, Schaufelberger H, Steinacher R, Schar P, et al
    DNA-methylation variability in normal mucosa: a field cancerization marker in patients with adenomatous polyps.
    J Natl Cancer Inst. 2024;116:974-982.
    PubMed     Abstract available
    
    
    
28. RANSOHOFF DF
    Evaluating a blood test for Colon cancer screening: how simulation modeling can inform clinical policy making and research.
    J Natl Cancer Inst. 2024 Jun 6:djae125. doi: 10.1093.
    PubMed    
    
    
    
29. NASCIMENTO DE LIMA P, Van Den Puttelaar R, Knudsen AB, Hahn AI, et al
    Characteristics of a cost-effective blood test for colorectal cancer screening.
    J Natl Cancer Inst. 2024 Jun 6:djae124. doi: 10.1093.
    PubMed     Abstract available
    
    
    May 2024
30. HOCHSTER HS, Catalano P, Weitz M, Mitchell EP, et al
    Combining anti-VEGFR and anti-EGFR antibodies: Randomized phase II study of irinotecan and cetuximab with/without ramucirumab in second-line colorectal cancer:(ECOG-ACRIN E7208).
    J Natl Cancer Inst. 2024 May 22:djae114. doi: 10.1093.
    PubMed     Abstract available
    
    
    
31. CORONADO GD, Bienen L, Burnett-Hartman A, Lee JK, et al
    Maximizing scarce colonoscopy resources: the crucial role of stool-based tests.
    J Natl Cancer Inst. 2024;116:647-652.
    PubMed     Abstract available
    
    
    April 2024
32. SUN J, Zhao J, Zhou S, Li X, et al
    Systematic investigation of genetically determined plasma and urinary metabolites to discover potential interventional targets for colorectal cancer.
    J Natl Cancer Inst. 2024 Apr 22:djae089. doi: 10.1093.
    PubMed     Abstract available
    
    
    
33. FANG A, Ugai T, Gurjao C, Zhong R, et al
    Alcohol and colorectal cancer risk subclassified by mutational signatures of DNA mismatch repair deficiency.
    J Natl Cancer Inst. 2024 Apr 4:djae078. doi: 10.1093.
    PubMed     Abstract available
    
    
    March 2024
34. BEVER AM, Hang D, Lee DH, Tabung FK, et al
    Metabolomic signatures of inflammation and metabolic dysregulation in relation to colorectal cancer risk.
    J Natl Cancer Inst. 2024 Mar 1:djae047. doi: 10.1093.
    PubMed     Abstract available
    
    
    
35. GOPALANI SV, Saraiya M, Huang B, Tucker TC, et al
    Population-level incidence of HPV-positive oropharyngeal, cervical, and anal cancers by smoking status.
    J Natl Cancer Inst. 2024 Mar 1:djae054. doi: 10.1093.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge.